Hybrid iron oxide-gold nanoparticles (HNPs) have shown potential in cancer therapy as agents for tumour ablation and thermal switches for targeted drug release. Heat generation occurs by exploitation of the surface plasmon resonance of the gold coating, which usually occurs at the maximum UV absorption wavelength. However, lasers at such wavelength are often expensive and highly specialised. Here, we report the heating and monitoring of heat dissipation of HNPs suspended in agar phantoms using a relatively inexpensive Ng: YAG pulsed 1064 nm laser source. The particles experience heating of up to 40°C with a total area of heat dissipation up to 132.73 mm2 from the 1 mm diameter irradiation point after 60 seconds. This work reports the potent...
Hybrid iron oxide-gold nanoparticles (HNPs) are capable of drug binding onto their surface with a tr...
Hybrid iron oxide-gold nanoparticles (HNPs) are capable of drug binding onto their surface with a tr...
Unidade de Ciencias Biomoleculares Aplicadas - UCIBIO - FCT/MEC (UID/Multi/04378/2013) ERDF (POCI-01...
Hybrid iron oxide-gold nanoparticles (HNPs) have shown potential in cancer therapy as agents for tum...
Hybrid iron oxide-gold nanoparticles (HNPs) have shown potential in cancer therapy as agents for tum...
Hybrid iron oxide-gold nanoparticles (HNPs) have shown potential in cancer therapy as agents for tum...
Theranostics are emerging platforms for rapid cancer diagnosis and therapy. Hybrid iron oxide–gold n...
Theranostics are emerging platforms for rapid cancer diagnosis and therapy. Hybrid iron oxide–gold n...
Theranostics are emerging platforms for rapid cancer diagnosis and therapy. Hybrid iron oxide–gold n...
Hybrid iron oxide-gold nanoparticles (HNPs) are capable of drug binding onto their surface with a tr...
Hybrid iron oxide–gold nanoparticles (HNPs) show the ability to bind drugs onto their surface with a...
Gold nanoparticles are prime candidates for cancer thermotherapy. However, while the ultimate target...
Background: Iron oxide nanoparticles (IONPs) have increasing applications in biomedicine, however f...
Background: Iron oxide nanoparticles (IONPs) have increasing applications in biomedicine, however f...
Hybrid iron oxide-gold nanoparticles (HNPs) are capable of drug binding onto their surface with a tr...
Hybrid iron oxide-gold nanoparticles (HNPs) are capable of drug binding onto their surface with a tr...
Hybrid iron oxide-gold nanoparticles (HNPs) are capable of drug binding onto their surface with a tr...
Unidade de Ciencias Biomoleculares Aplicadas - UCIBIO - FCT/MEC (UID/Multi/04378/2013) ERDF (POCI-01...
Hybrid iron oxide-gold nanoparticles (HNPs) have shown potential in cancer therapy as agents for tum...
Hybrid iron oxide-gold nanoparticles (HNPs) have shown potential in cancer therapy as agents for tum...
Hybrid iron oxide-gold nanoparticles (HNPs) have shown potential in cancer therapy as agents for tum...
Theranostics are emerging platforms for rapid cancer diagnosis and therapy. Hybrid iron oxide–gold n...
Theranostics are emerging platforms for rapid cancer diagnosis and therapy. Hybrid iron oxide–gold n...
Theranostics are emerging platforms for rapid cancer diagnosis and therapy. Hybrid iron oxide–gold n...
Hybrid iron oxide-gold nanoparticles (HNPs) are capable of drug binding onto their surface with a tr...
Hybrid iron oxide–gold nanoparticles (HNPs) show the ability to bind drugs onto their surface with a...
Gold nanoparticles are prime candidates for cancer thermotherapy. However, while the ultimate target...
Background: Iron oxide nanoparticles (IONPs) have increasing applications in biomedicine, however f...
Background: Iron oxide nanoparticles (IONPs) have increasing applications in biomedicine, however f...
Hybrid iron oxide-gold nanoparticles (HNPs) are capable of drug binding onto their surface with a tr...
Hybrid iron oxide-gold nanoparticles (HNPs) are capable of drug binding onto their surface with a tr...
Hybrid iron oxide-gold nanoparticles (HNPs) are capable of drug binding onto their surface with a tr...
Unidade de Ciencias Biomoleculares Aplicadas - UCIBIO - FCT/MEC (UID/Multi/04378/2013) ERDF (POCI-01...